Preclinical safety and efficacy of human CD34(+) cells transduced with lentiviral vector for the treatment of Wiskott-Aldrich syndrome (Q33399943)
Jump to navigation
Jump to search
scientific article
- Preclinical Safety and Efficacy of Human CD34+ Cells Transduced With Lentiviral Vector for the Treatment of Wiskott-Aldrich Syndrome.
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Preclinical safety and efficacy of human CD34(+) cells transduced with lentiviral vector for the treatment of Wiskott-Aldrich syndrome |
scientific article |
|
Statements
2 references
Preclinical safety and efficacy of human CD34(+) cells transduced with lentiviral vector for the treatment of Wiskott-Aldrich syndrome (English)
1 reference
Preclinical Safety and Efficacy of Human CD34+ Cells Transduced With Lentiviral Vector for the Treatment of Wiskott-Aldrich Syndrome (English)
1 reference
Manfred Schmidt
2 references
Samantha Scaramuzza
2 references
Luca Biasco
2 references
Anna Ripamonti
2 references
Mariana Loperfido
2 references
Elena Draghici
2 references
Raisa J Hernandez
2 references
Fabrizio Benedicenti
2 references
Marina Radrizzani
2 references
Monica Salomoni
2 references
Marco Ranzani
2 references
Cynthia C Bartholomae
2 references
Robbert Bredius
2 references
Marita Bosticardo
2 references
Alessandra Biffi
2 references
28 February 2012
1 reference
1 January 2013
1 reference
2 references
21
2 references
1
2 references
175-184
2 references
1 reference
1 reference
Identifiers
2 references